Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
COngenital Multicenter Trial of Pulmonic vAlve Dysfunction Studying the SAPIEN 3 interventIONal THV
Status: Enrolling
Updated:  12/31/1969
University of Virginia (UVA)
mi
from
Charlottesville, VA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
COngenital Multicenter Trial of Pulmonic vAlve Dysfunction Studying the SAPIEN 3 interventIONal THV
Status: Enrolling
Updated: 12/31/1969
University of Virginia (UVA)
mi
from
Charlottesville, VA
Click here to add this to my saved trials
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
COngenital Multicenter Trial of Pulmonic vAlve Dysfunction Studying the SAPIEN 3 interventIONal THV
Status: Enrolling
Updated:  12/31/1969
University of Washington, Seattle Children's Hospital
mi
from
Seattle, WA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
COngenital Multicenter Trial of Pulmonic vAlve Dysfunction Studying the SAPIEN 3 interventIONal THV
Status: Enrolling
Updated: 12/31/1969
University of Washington, Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Role of Podocan and Wnt Pathway Regulatory Molecules in Coronary Artery Disease
Role of Podocan and Wnt Pathway Regulatory Molecules in Coronary Artery Disease
Status: Enrolling
Updated:  12/31/1969
Bassett Healthcare Network
mi
from
Cooperstown, NY
Role of Podocan and Wnt Pathway Regulatory Molecules in Coronary Artery Disease
Role of Podocan and Wnt Pathway Regulatory Molecules in Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
Bassett Healthcare Network
mi
from
Cooperstown, NY
Click here to add this to my saved trials
Study to Evaluate the Effect of Nicotinamide Riboside on Immunity
Study to Evaluate the Effect of Nicotinamide Riboside on Immunity
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Study to Evaluate the Effect of Nicotinamide Riboside on Immunity
Study to Evaluate the Effect of Nicotinamide Riboside on Immunity
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Women's INternational Transcatheter Aortic Valve Implantation Registry
Women's INternational Transcatheter Aortic Valve Implantation Registry
Status: Enrolling
Updated:  12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Women's INternational Transcatheter Aortic Valve Implantation Registry
Women's INternational Transcatheter Aortic Valve Implantation Registry
Status: Enrolling
Updated: 12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Women's INternational Transcatheter Aortic Valve Implantation Registry
Women's INternational Transcatheter Aortic Valve Implantation Registry
Status: Enrolling
Updated:  12/31/1969
Hôpital Privé Parly 2
mi
from
Le Chesnay,
Women's INternational Transcatheter Aortic Valve Implantation Registry
Women's INternational Transcatheter Aortic Valve Implantation Registry
Status: Enrolling
Updated: 12/31/1969
Hôpital Privé Parly 2
mi
from
Le Chesnay,
Click here to add this to my saved trials
Open Lung Strategy in Critically Ill Morbid Obese Patients
Open Lung Strategy in Critically Ill Morbid Obese Patients Lung Imaging and Heart-lung Interaction
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Open Lung Strategy in Critically Ill Morbid Obese Patients
Open Lung Strategy in Critically Ill Morbid Obese Patients Lung Imaging and Heart-lung Interaction
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Genetic Factors in Atherosclerosis
Chemokine System Polymorphisms and Risk of Atherosclerosis (CAD)
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Genetic Factors in Atherosclerosis
Chemokine System Polymorphisms and Risk of Atherosclerosis (CAD)
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
CADASIL Disease Discovery
CADASIL Disease Discovery
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
CADASIL Disease Discovery
CADASIL Disease Discovery
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
The Medtronic TAVR 2.0 US Clinical Study
The Medtronic TAVR 2.0 US Clinical Study
Status: Enrolling
Updated:  12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
The Medtronic TAVR 2.0 US Clinical Study
The Medtronic TAVR 2.0 US Clinical Study
Status: Enrolling
Updated: 12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
The Medtronic TAVR 2.0 US Clinical Study
The Medtronic TAVR 2.0 US Clinical Study
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
The Medtronic TAVR 2.0 US Clinical Study
The Medtronic TAVR 2.0 US Clinical Study
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
The Medtronic TAVR 2.0 US Clinical Study
The Medtronic TAVR 2.0 US Clinical Study
Status: Enrolling
Updated:  12/31/1969
NYU Langone Medical Center
mi
from
New York, NY
The Medtronic TAVR 2.0 US Clinical Study
The Medtronic TAVR 2.0 US Clinical Study
Status: Enrolling
Updated: 12/31/1969
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
The Medtronic TAVR 2.0 US Clinical Study
The Medtronic TAVR 2.0 US Clinical Study
Status: Enrolling
Updated:  12/31/1969
OhioHealth Riverside Methodist Hospital
mi
from
Columbus, OH
The Medtronic TAVR 2.0 US Clinical Study
The Medtronic TAVR 2.0 US Clinical Study
Status: Enrolling
Updated: 12/31/1969
OhioHealth Riverside Methodist Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
The Medtronic TAVR 2.0 US Clinical Study
The Medtronic TAVR 2.0 US Clinical Study
Status: Enrolling
Updated:  12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
The Medtronic TAVR 2.0 US Clinical Study
The Medtronic TAVR 2.0 US Clinical Study
Status: Enrolling
Updated: 12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
The Medtronic TAVR 2.0 US Clinical Study
The Medtronic TAVR 2.0 US Clinical Study
Status: Enrolling
Updated:  12/31/1969
University of Kansas Hospital
mi
from
Kansas City, KA
The Medtronic TAVR 2.0 US Clinical Study
The Medtronic TAVR 2.0 US Clinical Study
Status: Enrolling
Updated: 12/31/1969
University of Kansas Hospital
mi
from
Kansas City, KA
Click here to add this to my saved trials
The Medtronic TAVR 2.0 US Clinical Study
The Medtronic TAVR 2.0 US Clinical Study
Status: Enrolling
Updated:  12/31/1969
Morristown Memorial Hospital
mi
from
Morristown, NJ
The Medtronic TAVR 2.0 US Clinical Study
The Medtronic TAVR 2.0 US Clinical Study
Status: Enrolling
Updated: 12/31/1969
Morristown Memorial Hospital
mi
from
Morristown, NJ
Click here to add this to my saved trials
The Medtronic TAVR 2.0 US Clinical Study
The Medtronic TAVR 2.0 US Clinical Study
Status: Enrolling
Updated:  12/31/1969
New York Presbyterian Hospital - Columbia University Medical Center
mi
from
New York, NY
The Medtronic TAVR 2.0 US Clinical Study
The Medtronic TAVR 2.0 US Clinical Study
Status: Enrolling
Updated: 12/31/1969
New York Presbyterian Hospital - Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated:  12/31/1969
Study Site 16101
mi
from
Birmingham, AL
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated: 12/31/1969
Study Site 16101
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated:  12/31/1969
Study Site 16078
mi
from
Huntsville, AL
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated: 12/31/1969
Study Site 16078
mi
from
Huntsville, AL
Click here to add this to my saved trials
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated:  12/31/1969
Study Site - 16168
mi
from
Concord, CA
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated: 12/31/1969
Study Site - 16168
mi
from
Concord, CA
Click here to add this to my saved trials
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated:  12/31/1969
Study Site 16130
mi
from
Littleton, CO
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated: 12/31/1969
Study Site 16130
mi
from
Littleton, CO
Click here to add this to my saved trials
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated:  12/31/1969
Study Site 16135
mi
from
Danbury, CT
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated: 12/31/1969
Study Site 16135
mi
from
Danbury, CT
Click here to add this to my saved trials
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated:  12/31/1969
Study Site 16003
mi
from
Jacksonville, FL
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated: 12/31/1969
Study Site 16003
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated:  12/31/1969
Study Site 16112
mi
from
Boise, ID
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated: 12/31/1969
Study Site 16112
mi
from
Boise, ID
Click here to add this to my saved trials
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated:  12/31/1969
Study Site 16208
mi
from
Alexandria, LA
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated: 12/31/1969
Study Site 16208
mi
from
Alexandria, LA
Click here to add this to my saved trials
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated:  12/31/1969
Study Site 16061
mi
from
Petoskey, MI
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated: 12/31/1969
Study Site 16061
mi
from
Petoskey, MI
Click here to add this to my saved trials
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated:  12/31/1969
Study Site 16056
mi
from
Durham, NC
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated: 12/31/1969
Study Site 16056
mi
from
Durham, NC
Click here to add this to my saved trials
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated:  12/31/1969
Study Site 16018
mi
from
Rapid City, SD
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated: 12/31/1969
Study Site 16018
mi
from
Rapid City, SD
Click here to add this to my saved trials
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated:  12/31/1969
Study Site 16241
mi
from
Wichita Falls, TX
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated: 12/31/1969
Study Site 16241
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated:  12/31/1969
Study Site 17001
mi
from
Freiburg,
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated: 12/31/1969
Study Site 17001
mi
from
Freiburg,
Click here to add this to my saved trials
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated:  12/31/1969
Study Site 16014
mi
from
High Point, NC
A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Moderate Renal Impairment and Acute Myocardial Infarction
Status: Enrolling
Updated: 12/31/1969
Study Site 16014
mi
from
High Point, NC
Click here to add this to my saved trials
Coronary Flow Reserve to Assess Cardiovascular Inflammation (CIRT-CFR)
Coronary Flow Reserve to Assess Cardiovascular Inflammation (CIRT-CFR)
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Coronary Flow Reserve to Assess Cardiovascular Inflammation (CIRT-CFR)
Coronary Flow Reserve to Assess Cardiovascular Inflammation (CIRT-CFR)
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Pipeline for Uncoilable or Failed Aneurysms
Pipeline for Uncoilable or Failed Aneurysms
Status: Enrolling
Updated:  12/31/1969
Barrow Neurological Institute
mi
from
Phoenix, AZ
Pipeline for Uncoilable or Failed Aneurysms
Pipeline for Uncoilable or Failed Aneurysms
Status: Enrolling
Updated: 12/31/1969
Barrow Neurological Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Pipeline for Uncoilable or Failed Aneurysms
Pipeline for Uncoilable or Failed Aneurysms
Status: Enrolling
Updated:  12/31/1969
Rush University
mi
from
Chicago, IL
Pipeline for Uncoilable or Failed Aneurysms
Pipeline for Uncoilable or Failed Aneurysms
Status: Enrolling
Updated: 12/31/1969
Rush University
mi
from
Chicago, IL
Click here to add this to my saved trials
Pipeline for Uncoilable or Failed Aneurysms
Pipeline for Uncoilable or Failed Aneurysms
Status: Enrolling
Updated:  12/31/1969
Central Du Page Hospital
mi
from
Winfield, IL
Pipeline for Uncoilable or Failed Aneurysms
Pipeline for Uncoilable or Failed Aneurysms
Status: Enrolling
Updated: 12/31/1969
Central Du Page Hospital
mi
from
Winfield, IL
Click here to add this to my saved trials
Pipeline for Uncoilable or Failed Aneurysms
Pipeline for Uncoilable or Failed Aneurysms
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Pipeline for Uncoilable or Failed Aneurysms
Pipeline for Uncoilable or Failed Aneurysms
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Pipeline for Uncoilable or Failed Aneurysms
Pipeline for Uncoilable or Failed Aneurysms
Status: Enrolling
Updated:  12/31/1969
University at Buffalo
mi
from
Buffalo, NY
Pipeline for Uncoilable or Failed Aneurysms
Pipeline for Uncoilable or Failed Aneurysms
Status: Enrolling
Updated: 12/31/1969
University at Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Pipeline for Uncoilable or Failed Aneurysms
Pipeline for Uncoilable or Failed Aneurysms
Status: Enrolling
Updated:  12/31/1969
New York University
mi
from
New York, NY
Pipeline for Uncoilable or Failed Aneurysms
Pipeline for Uncoilable or Failed Aneurysms
Status: Enrolling
Updated: 12/31/1969
New York University
mi
from
New York, NY
Click here to add this to my saved trials
Pipeline for Uncoilable or Failed Aneurysms
Pipeline for Uncoilable or Failed Aneurysms
Status: Enrolling
Updated:  12/31/1969
Stony Brook University
mi
from
Stony Brook, NY
Pipeline for Uncoilable or Failed Aneurysms
Pipeline for Uncoilable or Failed Aneurysms
Status: Enrolling
Updated: 12/31/1969
Stony Brook University
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Pipeline for Uncoilable or Failed Aneurysms
Pipeline for Uncoilable or Failed Aneurysms
Status: Enrolling
Updated:  12/31/1969
National Institute of Neurosurgery
mi
from
Budapest,
Pipeline for Uncoilable or Failed Aneurysms
Pipeline for Uncoilable or Failed Aneurysms
Status: Enrolling
Updated: 12/31/1969
National Institute of Neurosurgery
mi
from
Budapest,
Click here to add this to my saved trials
Pipeline for Uncoilable or Failed Aneurysms
Pipeline for Uncoilable or Failed Aneurysms
Status: Enrolling
Updated:  12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Pipeline for Uncoilable or Failed Aneurysms
Pipeline for Uncoilable or Failed Aneurysms
Status: Enrolling
Updated: 12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema
Open-Label Study of the Safety and Efficacy of Suprachoroidal CLS-TA Alone or in Combination With Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Vitreous Associates Medical Group Inc
mi
from
Mountain View, CA
Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema
Open-Label Study of the Safety and Efficacy of Suprachoroidal CLS-TA Alone or in Combination With Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Vitreous Associates Medical Group Inc
mi
from
Mountain View, CA
Click here to add this to my saved trials
Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema
Open-Label Study of the Safety and Efficacy of Suprachoroidal CLS-TA Alone or in Combination With Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Houston
mi
from
The Woodlands, TX
Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema
Open-Label Study of the Safety and Efficacy of Suprachoroidal CLS-TA Alone or in Combination With Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin and Sitagliptin in Patients With Type 2 Diabetes Mellitus and Heart Failure
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Torrance, CA
Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin and Sitagliptin in Patients With Type 2 Diabetes Mellitus and Heart Failure
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin and Sitagliptin in Patients With Type 2 Diabetes Mellitus and Heart Failure
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin and Sitagliptin in Patients With Type 2 Diabetes Mellitus and Heart Failure
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin and Sitagliptin in Patients With Type 2 Diabetes Mellitus and Heart Failure
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Kansas City, MO
Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin and Sitagliptin in Patients With Type 2 Diabetes Mellitus and Heart Failure
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin and Sitagliptin in Patients With Type 2 Diabetes Mellitus and Heart Failure
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Sayre, PA
Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin and Sitagliptin in Patients With Type 2 Diabetes Mellitus and Heart Failure
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sayre, PA
Click here to add this to my saved trials
Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin and Sitagliptin in Patients With Type 2 Diabetes Mellitus and Heart Failure
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Spartanburg, SC
Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin and Sitagliptin in Patients With Type 2 Diabetes Mellitus and Heart Failure
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin and Sitagliptin in Patients With Type 2 Diabetes Mellitus and Heart Failure
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin and Sitagliptin in Patients With Type 2 Diabetes Mellitus and Heart Failure
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin and Sitagliptin in Patients With Type 2 Diabetes Mellitus and Heart Failure
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Upland, CA
Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure
A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin and Sitagliptin in Patients With Type 2 Diabetes Mellitus and Heart Failure
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Upland, CA
Click here to add this to my saved trials